These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 28565878

  • 1. Ginsenoside Rb3 strengthens the hypoglycemic effect through AMPK for inhibition of hepatic gluconeogenesis.
    Meng F, Su X, Li W, Zheng Y.
    Exp Ther Med; 2017 May; 13(5):2551-2557. PubMed ID: 28565878
    [Abstract] [Full Text] [Related]

  • 2. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
    Wei S, Li W, Yu Y, Yao F, A L, Lan X, Guan F, Zhang M, Chen L.
    Life Sci; 2015 Oct 15; 139():8-15. PubMed ID: 26285176
    [Abstract] [Full Text] [Related]

  • 3. Involvement of AMPK activation in the inhibition of hepatic gluconeogenesis by Ficus carica leaf extract in diabetic mice and HepG2 cells.
    Zhang Y, Chen J, Zeng Y, Huang D, Xu Q.
    Biomed Pharmacother; 2019 Jan 15; 109():188-194. PubMed ID: 30396076
    [Abstract] [Full Text] [Related]

  • 4. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
    Zhang M, Lv X, Li J, Meng Z, Wang Q, Chang W, Li W, Chen L, Liu Y.
    Mol Cell Endocrinol; 2012 Nov 05; 363(1-2):122-30. PubMed ID: 22922125
    [Abstract] [Full Text] [Related]

  • 5. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase.
    Wu XM, Ren T, Liu JF, Liu YJ, Yang LC, Jin X.
    Biomed Pharmacother; 2018 Jul 05; 103():1384-1391. PubMed ID: 29864922
    [Abstract] [Full Text] [Related]

  • 6. Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells.
    Kim SJ, Yuan HD, Chung SH.
    Biol Pharm Bull; 2010 Jul 05; 33(2):325-8. PubMed ID: 20118562
    [Abstract] [Full Text] [Related]

  • 7. Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells.
    Yuan HD, Kim DY, Quan HY, Kim SJ, Jung MS, Chung SH.
    Chem Biol Interact; 2012 Jan 05; 195(1):35-42. PubMed ID: 22062806
    [Abstract] [Full Text] [Related]

  • 8. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway.
    Liu Y, Deng J, Fan D.
    Food Funct; 2019 May 22; 10(5):2538-2551. PubMed ID: 30993294
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AKT/FOXO Signaling Pathway.
    Lee J, Hong SW, Kim MJ, Lim YM, Moon SJ, Kwon H, Park SE, Rhee EJ, Lee WY.
    Endocrinol Metab (Seoul); 2024 Feb 22; 39(1):98-108. PubMed ID: 38171209
    [Abstract] [Full Text] [Related]

  • 10. Cyclocarya paliurus triterpenoids suppress hepatic gluconeogenesis via AMPK-mediated cAMP/PKA/CREB pathway.
    Cao J, Zheng R, Chang X, Zhao Y, Zhang D, Gao M, Yin Z, Jiang C, Zhang J.
    Phytomedicine; 2022 Jul 20; 102():154175. PubMed ID: 35609386
    [Abstract] [Full Text] [Related]

  • 11. An active part of Artemisia sacrorum Ledeb. suppresses gluconeogenesis through AMPK mediated GSK3β and CREB phosphorylation in human HepG2 cells.
    Yuan HD, Piao GC.
    Biosci Biotechnol Biochem; 2011 Jul 20; 75(6):1079-84. PubMed ID: 21670525
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Itraconazole attenuates hepatic gluconeogenesis and promotes glucose uptake by regulating AMPK pathway.
    Na RS, Ma C, Liu QR, Wu LM, Zheng XL, Liu ZW.
    Exp Ther Med; 2018 Feb 20; 15(2):2165-2171. PubMed ID: 29434820
    [Abstract] [Full Text] [Related]

  • 15. Geniposide Suppresses Hepatic Glucose Production via AMPK in HepG2 Cells.
    Guo L, Zheng X, Liu J, Yin Z.
    Biol Pharm Bull; 2016 Feb 20; 39(4):484-91. PubMed ID: 26830672
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, Jang WG, Cho WJ, Ha J, Lee IK, Lee CH, Choi HS.
    Diabetes; 2008 Feb 20; 57(2):306-14. PubMed ID: 17909097
    [Abstract] [Full Text] [Related]

  • 18. Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway.
    Yoshida H, Ishii M, Akagawa M.
    Arch Biochem Biophys; 2019 Sep 15; 672():108057. PubMed ID: 31356781
    [Abstract] [Full Text] [Related]

  • 19. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
    Wei S, Zhang M, Yu Y, Lan X, Yao F, Yan X, Chen L, Hatch GM.
    PLoS One; 2016 Sep 15; 11(3):e0152097. PubMed ID: 27011261
    [Abstract] [Full Text] [Related]

  • 20. GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1.
    Sakamaki J, Daitoku H, Kaneko Y, Hagiwara A, Ueno K, Fukamizu A.
    J Recept Signal Transduct Res; 2012 Apr 15; 32(2):96-101. PubMed ID: 22384829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.